Lu, Z., Chen, H., Jiao, X., Wang, Y., Wu, L., Sun, H., . . . Shen, L. (2021). Germline HLA-B evolutionary divergence influences the efficacy of immune checkpoint blockade therapy in gastrointestinal cancer. BMC.
Cita Chicago Style (17a ed.)Lu, Zhihao, et al. Germline HLA-B Evolutionary Divergence Influences the Efficacy of Immune Checkpoint Blockade Therapy in Gastrointestinal Cancer. BMC, 2021.
Cita MLA (8a ed.)Lu, Zhihao, et al. Germline HLA-B Evolutionary Divergence Influences the Efficacy of Immune Checkpoint Blockade Therapy in Gastrointestinal Cancer. BMC, 2021.
Precaución: Estas citas no son 100% exactas.